CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?

Rheumatology (Oxford). 2024 May 2;63(5):1192-1194. doi: 10.1093/rheumatology/keae108.

Authors

Sander I van Leuven¹, Raphaël Duivenvoorden^{2

3}

Affiliations

¹ Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
² Department of Nephrology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Biomolecular Engineering and Imaging Institute, Icahn School of Medicine, Mount Sinai, New York, NY, USA.

PMID: 38377390
DOI: 10.1093/rheumatology/keae108

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunotherapy, Adoptive* / methods
Lupus Erythematosus, Systemic* / therapy
Receptors, Chimeric Antigen / immunology
T-Lymphocytes / immunology

Substances

Receptors, Chimeric Antigen